The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

The Japanese regulator looks like it could follow the European Commission and reject approval of Biogen and ... and Medical Devices Agency (PMDA) in Japan "to agree on additional data requirements ...